BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21424539)

  • 21. Involvement of human heparanase in the pathogenesis of diabetic nephropathy.
    Katz A; Van-Dijk DJ; Aingorn H; Erman A; Davies M; Darmon D; Hurvitz H; Vlodavsky I
    Isr Med Assoc J; 2002 Nov; 4(11):996-1002. PubMed ID: 12489489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial cell heparanase taken up by cardiomyocytes regulates lipoprotein lipase transfer to the coronary lumen after diabetes.
    Wang Y; Chiu AP; Neumaier K; Wang F; Zhang D; Hussein B; Lal N; Wan A; Liu G; Vlodavsky I; Rodrigues B
    Diabetes; 2014 Aug; 63(8):2643-55. PubMed ID: 24608441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression.
    An X; Zhang L; Yuan Y; Wang B; Yao Q; Li L; Zhang J; He M; Zhang J
    Sci Rep; 2017 Jul; 7(1):6413. PubMed ID: 28743882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of heparanase expression in coronary artery disease in diabetic, hyperlipidemic swine.
    Baker AB; Chatzizisis YS; Beigel R; Jonas M; Stone BV; Coskun AU; Maynard C; Rogers C; Koskinas KC; Feldman CL; Stone PH; Edelman ER
    Atherosclerosis; 2010 Dec; 213(2):436-42. PubMed ID: 20950809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of JAK2/STAT3-mediated VEGF upregulation under high glucose conditions by PEDF through a mitochondrial ROS pathway in vitro.
    Zheng Z; Chen H; Zhao H; Liu K; Luo D; Chen Y; Chen Y; Yang X; Gu Q; Xu X
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):64-71. PubMed ID: 19696171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species.
    Yu T; Sheu SS; Robotham JL; Yoon Y
    Cardiovasc Res; 2008 Jul; 79(2):341-51. PubMed ID: 18440987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated glucose decreases the content of a basement membrane associated heparan sulphate proteoglycan in proliferating cultured porcine mesangial cells.
    Olgemöller B; Schwaabe S; Gerbitz KD; Schleicher ED
    Diabetologia; 1992 Feb; 35(2):183-6. PubMed ID: 1547925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mammalian heparanase: what is the message?
    Vreys V; David G
    J Cell Mol Med; 2007; 11(3):427-52. PubMed ID: 17635638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
    Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
    Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Traditional Chinese medicine xin-mai-jia recouples endothelial nitric oxide synthase to prevent atherosclerosis in vivo.
    Yin YL; Zhu ML; Wan J; Zhang C; Pan GP; Lu JX; Ping S; Chen Y; Zhao FR; Yu HY; Guo T; Jian X; Liu LY; Zhang JN; Wan GR; Wang SX; Li P
    Sci Rep; 2017 Mar; 7():43508. PubMed ID: 28252100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-like receptors 2 and 4 mediate hyperglycemia induced macrovascular aortic endothelial cell inflammation and perturbation of the endothelial glycocalyx.
    Pahwa R; Nallasamy P; Jialal I
    J Diabetes Complications; 2016; 30(4):563-72. PubMed ID: 26908090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function.
    Suzuki K; Olah G; Modis K; Coletta C; Kulp G; Gerö D; Szoleczky P; Chang T; Zhou Z; Wu L; Wang R; Papapetropoulos A; Szabo C
    Proc Natl Acad Sci U S A; 2011 Aug; 108(33):13829-34. PubMed ID: 21808008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scutellarin protects against vascular endothelial dysfunction and prevents atherosclerosis via antioxidation.
    Mo J; Yang R; Li F; Zhang X; He B; Zhang Y; Chen P; Shen Z
    Phytomedicine; 2018 Mar; 42():66-74. PubMed ID: 29655699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multidrug resistance associated protein-1 (MRP1) deficiency attenuates endothelial dysfunction in diabetes.
    Neuser J; Fraccarollo D; Wick M; Bauersachs J; Widder JD
    J Diabetes Complications; 2016; 30(4):623-7. PubMed ID: 26908299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Argirein alleviates vascular endothelial insulin resistance through suppressing the activation of Nox4-dependent O
    Li Q; Su J; Jin SJ; Wei W; Cong XD; Li XX; Xu M
    Free Radic Biol Med; 2018 Jun; 121():169-179. PubMed ID: 29709706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glomerular proteoglycans in diabetes. Partial structural characterization and metabolism of de novo synthesized heparan-35SO4 and dermatan-35SO4 proteoglycans in streptozocin-induced diabetic rats.
    Klein DJ; Brown DM; Oegema TR
    Diabetes; 1986 Oct; 35(10):1130-42. PubMed ID: 2944782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vildagliptin improves high glucose-induced endothelial mitochondrial dysfunction via inhibiting mitochondrial fission.
    Liu H; Xiang H; Zhao S; Sang H; Lv F; Chen R; Shu Z; Chen AF; Chen S; Lu H
    J Cell Mol Med; 2019 Feb; 23(2):798-810. PubMed ID: 30444033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-glucose-induced structural changes in the heparan sulfate proteoglycan, perlecan, of cultured human aortic endothelial cells.
    Vogl-Willis CA; Edwards IJ
    Biochim Biophys Acta; 2004 Apr; 1672(1):36-45. PubMed ID: 15056491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelial cells respond to hyperglycemia by increasing the LPL transporter GPIHBP1.
    Pei-Ling Chiu A; Wang F; Lal N; Wang Y; Zhang D; Hussein B; Wan A; Vlodavsky I; Rodrigues B
    Am J Physiol Endocrinol Metab; 2014 Jun; 306(11):E1274-83. PubMed ID: 24735886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukocyte-derived myeloperoxidase amplifies high-glucose--induced endothelial dysfunction through interaction with high-glucose--stimulated, vascular non--leukocyte-derived reactive oxygen species.
    Zhang C; Yang J; Jennings LK
    Diabetes; 2004 Nov; 53(11):2950-9. PubMed ID: 15504976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.